COVID-19 Impact on Global Nano Antibodies Market Size, Status and Forecast 2020-2026

August 2020 | 98 pages | ID: C90377B281E7EN
QYResearch

Abstracts

This report focuses on the global Nano Antibodies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Nano Antibodies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Ablynx
• PREGENE
• Alphamab
• PersonGen

Market segment by Type, the product can be split into

• Monovalent Nanobody
• Multivalent and multispecific Nanobodies
• Fusion Nanobody

Market segment by Application, split into

• Disease detection in vitro
• Non-invasive diagnosis in vivo
• Tumor targeted therapy
• Nervous system disease
• Circulatory disease
• Infectious disease
• Other

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Nano Antibodies status, future forecast, growth opportunity, key market and key players.
• To present the Nano Antibodies development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Nano Antibodies are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Nano Antibodies Revenue
1.4 Market Analysis by Type
  1.4.1 Global Nano Antibodies Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Monovalent Nanobody
  1.4.3 Multivalent and multispecific Nanobodies
  1.4.4 Fusion Nanobody
1.5 Market by Application
  1.5.1 Global Nano Antibodies Market Share by Application: 2020 VS 2026
  1.5.2 Disease detection in vitro
  1.5.3 Non-invasive diagnosis in vivo
  1.5.4 Tumor targeted therapy
  1.5.5 Nervous system disease
  1.5.6 Circulatory disease
  1.5.7 Infectious disease
  1.5.8 Other
1.6 Coronavirus Disease 2019 (Covid-19): Nano Antibodies Industry Impact
  1.6.1 How the Covid-19 is Affecting the Nano Antibodies Industry
    1.6.1.1 Nano Antibodies Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Nano Antibodies Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Nano Antibodies Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Nano Antibodies Market Perspective (2015-2026)
2.2 Nano Antibodies Growth Trends by Regions
  2.2.1 Nano Antibodies Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Nano Antibodies Historic Market Share by Regions (2015-2020)
  2.2.3 Nano Antibodies Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Nano Antibodies Market Growth Strategy
  2.3.6 Primary Interviews with Key Nano Antibodies Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Nano Antibodies Players by Market Size
  3.1.1 Global Top Nano Antibodies Players by Revenue (2015-2020)
  3.1.2 Global Nano Antibodies Revenue Market Share by Players (2015-2020)
  3.1.3 Global Nano Antibodies Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Nano Antibodies Market Concentration Ratio
  3.2.1 Global Nano Antibodies Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Nano Antibodies Revenue in 2019
3.3 Nano Antibodies Key Players Head office and Area Served
3.4 Key Players Nano Antibodies Product Solution and Service
3.5 Date of Enter into Nano Antibodies Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Nano Antibodies Historic Market Size by Type (2015-2020)
4.2 Global Nano Antibodies Forecasted Market Size by Type (2021-2026)

5 NANO ANTIBODIES BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Nano Antibodies Market Size by Application (2015-2020)
5.2 Global Nano Antibodies Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Nano Antibodies Market Size (2015-2020)
6.2 Nano Antibodies Key Players in North America (2019-2020)
6.3 North America Nano Antibodies Market Size by Type (2015-2020)
6.4 North America Nano Antibodies Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Nano Antibodies Market Size (2015-2020)
7.2 Nano Antibodies Key Players in Europe (2019-2020)
7.3 Europe Nano Antibodies Market Size by Type (2015-2020)
7.4 Europe Nano Antibodies Market Size by Application (2015-2020)

8 CHINA

8.1 China Nano Antibodies Market Size (2015-2020)
8.2 Nano Antibodies Key Players in China (2019-2020)
8.3 China Nano Antibodies Market Size by Type (2015-2020)
8.4 China Nano Antibodies Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Nano Antibodies Market Size (2015-2020)
9.2 Nano Antibodies Key Players in Japan (2019-2020)
9.3 Japan Nano Antibodies Market Size by Type (2015-2020)
9.4 Japan Nano Antibodies Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Nano Antibodies Market Size (2015-2020)
10.2 Nano Antibodies Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Nano Antibodies Market Size by Type (2015-2020)
10.4 Southeast Asia Nano Antibodies Market Size by Application (2015-2020)

11 INDIA

11.1 India Nano Antibodies Market Size (2015-2020)
11.2 Nano Antibodies Key Players in India (2019-2020)
11.3 India Nano Antibodies Market Size by Type (2015-2020)
11.4 India Nano Antibodies Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Nano Antibodies Market Size (2015-2020)
12.2 Nano Antibodies Key Players in Central & South America (2019-2020)
12.3 Central & South America Nano Antibodies Market Size by Type (2015-2020)
12.4 Central & South America Nano Antibodies Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Ablynx
  13.1.1 Ablynx Company Details
  13.1.2 Ablynx Business Overview and Its Total Revenue
  13.1.3 Ablynx Nano Antibodies Introduction
  13.1.4 Ablynx Revenue in Nano Antibodies Business (2015-2020))
  13.1.5 Ablynx Recent Development
13.2 PREGENE
  13.2.1 PREGENE Company Details
  13.2.2 PREGENE Business Overview and Its Total Revenue
  13.2.3 PREGENE Nano Antibodies Introduction
  13.2.4 PREGENE Revenue in Nano Antibodies Business (2015-2020)
  13.2.5 PREGENE Recent Development
13.3 Alphamab
  13.3.1 Alphamab Company Details
  13.3.2 Alphamab Business Overview and Its Total Revenue
  13.3.3 Alphamab Nano Antibodies Introduction
  13.3.4 Alphamab Revenue in Nano Antibodies Business (2015-2020)
  13.3.5 Alphamab Recent Development
13.4 PersonGen
  13.4.1 PersonGen Company Details
  13.4.2 PersonGen Business Overview and Its Total Revenue
  13.4.3 PersonGen Nano Antibodies Introduction
  13.4.4 PersonGen Revenue in Nano Antibodies Business (2015-2020)
  13.4.5 PersonGen Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Nano Antibodies Key Market Segments
Table 2. Key Players Covered: Ranking by Nano Antibodies Revenue
Table 3. Ranking of Global Top Nano Antibodies Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Nano Antibodies Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Monovalent Nanobody
Table 6. Key Players of Multivalent and multispecific Nanobodies
Table 7. Key Players of Fusion Nanobody
Table 8. COVID-19 Impact Global Market: (Four Nano Antibodies Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Nano Antibodies Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Nano Antibodies Players to Combat Covid-19 Impact
Table 13. Global Nano Antibodies Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Nano Antibodies Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Nano Antibodies Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Nano Antibodies Market Share by Regions (2015-2020)
Table 17. Global Nano Antibodies Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Nano Antibodies Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Nano Antibodies Market Growth Strategy
Table 23. Main Points Interviewed from Key Nano Antibodies Players
Table 24. Global Nano Antibodies Revenue by Players (2015-2020) (Million US$)
Table 25. Global Nano Antibodies Market Share by Players (2015-2020)
Table 26. Global Top Nano Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nano Antibodies as of 2019)
Table 27. Global Nano Antibodies by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Nano Antibodies Product Solution and Service
Table 30. Date of Enter into Nano Antibodies Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Nano Antibodies Market Size by Type (2015-2020) (Million US$)
Table 33. Global Nano Antibodies Market Size Share by Type (2015-2020)
Table 34. Global Nano Antibodies Revenue Market Share by Type (2021-2026)
Table 35. Global Nano Antibodies Market Size Share by Application (2015-2020)
Table 36. Global Nano Antibodies Market Size by Application (2015-2020) (Million US$)
Table 37. Global Nano Antibodies Market Size Share by Application (2021-2026)
Table 38. North America Key Players Nano Antibodies Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Nano Antibodies Market Share (2019-2020)
Table 40. North America Nano Antibodies Market Size by Type (2015-2020) (Million US$)
Table 41. North America Nano Antibodies Market Share by Type (2015-2020)
Table 42. North America Nano Antibodies Market Size by Application (2015-2020) (Million US$)
Table 43. North America Nano Antibodies Market Share by Application (2015-2020)
Table 44. Europe Key Players Nano Antibodies Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Nano Antibodies Market Share (2019-2020)
Table 46. Europe Nano Antibodies Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Nano Antibodies Market Share by Type (2015-2020)
Table 48. Europe Nano Antibodies Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Nano Antibodies Market Share by Application (2015-2020)
Table 50. China Key Players Nano Antibodies Revenue (2019-2020) (Million US$)
Table 51. China Key Players Nano Antibodies Market Share (2019-2020)
Table 52. China Nano Antibodies Market Size by Type (2015-2020) (Million US$)
Table 53. China Nano Antibodies Market Share by Type (2015-2020)
Table 54. China Nano Antibodies Market Size by Application (2015-2020) (Million US$)
Table 55. China Nano Antibodies Market Share by Application (2015-2020)
Table 56. Japan Key Players Nano Antibodies Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Nano Antibodies Market Share (2019-2020)
Table 58. Japan Nano Antibodies Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Nano Antibodies Market Share by Type (2015-2020)
Table 60. Japan Nano Antibodies Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Nano Antibodies Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Nano Antibodies Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Nano Antibodies Market Share (2019-2020)
Table 64. Southeast Asia Nano Antibodies Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Nano Antibodies Market Share by Type (2015-2020)
Table 66. Southeast Asia Nano Antibodies Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Nano Antibodies Market Share by Application (2015-2020)
Table 68. India Key Players Nano Antibodies Revenue (2019-2020) (Million US$)
Table 69. India Key Players Nano Antibodies Market Share (2019-2020)
Table 70. India Nano Antibodies Market Size by Type (2015-2020) (Million US$)
Table 71. India Nano Antibodies Market Share by Type (2015-2020)
Table 72. India Nano Antibodies Market Size by Application (2015-2020) (Million US$)
Table 73. India Nano Antibodies Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Nano Antibodies Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Nano Antibodies Market Share (2019-2020)
Table 76. Central & South America Nano Antibodies Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Nano Antibodies Market Share by Type (2015-2020)
Table 78. Central & South America Nano Antibodies Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Nano Antibodies Market Share by Application (2015-2020)
Table 80. Ablynx Company Details
Table 81. Ablynx Business Overview
Table 82. Ablynx Product
Table 83. Ablynx Revenue in Nano Antibodies Business (2015-2020) (Million US$)
Table 84. Ablynx Recent Development
Table 85. PREGENE Company Details
Table 86. PREGENE Business Overview
Table 87. PREGENE Product
Table 88. PREGENE Revenue in Nano Antibodies Business (2015-2020) (Million US$)
Table 89. PREGENE Recent Development
Table 90. Alphamab Company Details
Table 91. Alphamab Business Overview
Table 92. Alphamab Product
Table 93. Alphamab Revenue in Nano Antibodies Business (2015-2020) (Million US$)
Table 94. Alphamab Recent Development
Table 95. PersonGen Company Details
Table 96. PersonGen Business Overview
Table 97. PersonGen Product
Table 98. PersonGen Revenue in Nano Antibodies Business (2015-2020) (Million US$)
Table 99. PersonGen Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Nano Antibodies Market Share by Type: 2020 VS 2026
Figure 2. Monovalent Nanobody Features
Figure 3. Multivalent and multispecific Nanobodies Features
Figure 4. Fusion Nanobody Features
Figure 5. Global Nano Antibodies Market Share by Application: 2020 VS 2026
Figure 6. Disease detection in vitro Case Studies
Figure 7. Non-invasive diagnosis in vivo Case Studies
Figure 8. Tumor targeted therapy Case Studies
Figure 9. Nervous system disease Case Studies
Figure 10. Circulatory disease Case Studies
Figure 11. Infectious disease Case Studies
Figure 12. Other Case Studies
Figure 13. Nano Antibodies Report Years Considered
Figure 14. Global Nano Antibodies Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Nano Antibodies Market Share by Regions: 2020 VS 2026
Figure 16. Global Nano Antibodies Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Nano Antibodies Market Share by Players in 2019
Figure 19. Global Top Nano Antibodies Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nano Antibodies as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Nano Antibodies Revenue in 2019
Figure 21. North America Nano Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Nano Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Nano Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Nano Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Nano Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Nano Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Nano Antibodies Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Ablynx Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Ablynx Revenue Growth Rate in Nano Antibodies Business (2015-2020)
Figure 30. PREGENE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. PREGENE Revenue Growth Rate in Nano Antibodies Business (2015-2020)
Figure 32. Alphamab Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Alphamab Revenue Growth Rate in Nano Antibodies Business (2015-2020)
Figure 34. PersonGen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. PersonGen Revenue Growth Rate in Nano Antibodies Business (2015-2020)
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed